Ionis Pharmaceuticals Inc (NASDAQ:IONS)

62.45
BATS BZX Real-Time Price
As of 10:14am ET
 -0.29 / -0.46%
Today’s Change
44.52
Today|||52-Week Range
86.58
+15.52%
Year-to-Date
What Happened in the Stock Market Today
Oct 07 / MotleyFool.com - Paid Partner Content
A Biotech Set to Dominate the Next 20 Years
Oct 01 / MotleyFool.com - Paid Partner Content
Here's Why Akcea Therapeutics Jumped 30% Today
Oct 07 / MotleyFool.com - Paid Partner Content
Biogen's New Study to Test Higher Dose of SMA Drug Spinraza
Sep 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close62.74
Today’s open62.84
Day’s range62.35 - 63.00
Volume47,094
Average volume (3 months)1,026,232
Market cap$8.8B
Data as of 10:14am ET, 10/14/2019

Growth & Valuation

Earnings growth (last year)+2,515.50%
Earnings growth (this year)-102.17%
Earnings growth (next 5 years)+49.00%
Revenue growth (last year)+18.12%
P/E ratio21.0
Price/Sales12.09
Price/Book8.25

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-0.33-0.42%
GLPGGalapagos NV+0.16+0.10%
MYLMylan NV-0.35-1.85%
PRGOPerrigo Company PLC-0.47-0.88%
Data as of 10:16am ET, 10/14/2019

Financials

Next reporting dateNovember 4, 2019
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$599.7M
Annual profit (last year)$276.9M
Net profit margin46.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
Brett P. Monia
Corporate headquarters
Carlsbad, California

Forecasts